澤田武志 (Takeshi Sawada) - マイポータル

基本情報

学位: 医学博士(2016年3月神戸大学)

J-GLOBAL ID: 201401026630114907
researchmap会員ID: B000241894

研究分野

ライフサイエンス / 腫瘍診断、治療学 /

経歴

2020年2月 - 2021年3月

MSD株式会社, グローバル開発研究本部
2017年1月 - 2020年1月

MSD株式会社グローバル研究開発本部
2014年4月 - 2016年12月

日本医療研究開発機構（AMED), がん研究課リサーチレジデント
2014年4月 - 2016年12月

がん感染症センター都立駒込病院, 腫瘍内科非常勤医員
2012年4月 - 2014年3月

国立研究開発法人国立がん研究センター, 計画治療病棟支援施設リサーチレジデント
2009年4月 - 2012年3月

がん感染症センター都立駒込病院, 腫瘍内科専攻後期研修医
2007年4月 - 2009年3月

がん感染症センター都立駒込病院, 内科系初期研修医

学歴

2012年4月 - 2016年3月

神戸大学大学院, 医学系研究科, 血液・腫瘍内科専攻博士課程
2001年4月 - 2007年3月

神戸大学, 医学部, 医学科

受賞

論文

Author Correction: Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination

Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako E. Nakajima …

Nature Aging 3(6) 2023年5月2日
Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination

Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako E Nakajima …

The Journal of Immunology 210(1_Supplement) 2023年5月1日
Abstract 907: Evaluation of the anti-GPC1 scFv-Fc fusion protein as a detection tool of GPC1 expression in human cancers

Takeshi Sawada, Tomonori Yaguchi, Yuko Sakai, Chinatsu Suzuki, Kenji Morii, Masahiko Aoki, Masaru Fukahori, Satoshi Serada, Tetsuji Naka, Jun K. Yamashita …

Cancer Research 83(7_Supplement) 2023年4月4日
Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer.

Ryo Negishi, Hitomi Yamakawa, Takeru Kobayashi, Mayuko Horikawa, Tatsu Shimoyama, Fumiaki Koizumi, Takeshi Sawada, Keisuke Oboki, Yasushi Omuro, Chikako Funasaka …

Communications biology 5(1) 20-20 2022年1月11日
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC

Takayasu Kurata, Kazuhiko Nakagawa, Miyako Satouchi, Takashi Seto, Takeshi Sawada, Shirong Han, Masae Homma, Kazuo Noguchi, Naoyuki Nogami

Cancer Treatment and Research Communications 29 100458-100458 2021年
Primary results from Japanese phase I study of pembrolizumab plus chemotherapy as front-line therapy for advanced NSCLC

Takayasu Kurata, Kazuhiko Nakagawa, Miyako Satouchi, Takashi Seto, Takeshi Sawada, Shi Rong Han, Kazuo Noguchi, Takashi Shimamoto, Naoyuki Nogami

Annals of Oncology 30 2019年10月
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

Kaname Nosaki, Hideo Saka, Yukio Hosomi, Paul Baas, Gilberto de Castro Jr, Martin Reck, Yi-Long Wu, Julie R Brahmer, Enriqueta Felip, Takeshi Sawada …

Lung cancer (Amsterdam, Netherlands) 135 188-195 2019年9月査読有り
Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

K. Nosaki, Y. Hosomi, H. Saka, P. Baas, G. de Castro, M. Reck, Y.-L. Wu, J.R. Brahmer, E. Felip, T. Sawada …

Annals of Oncology 30 2019年4月
Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles.

Takeshi Sawada, Riet Hilhorst, Savithri Rangarajan, Masayuki Yoshida, Yuko Tanabe, Kenji Tamura, Takayuki Kinoshita, Tatsu Shimoyama, Rinie van Beuningen, Rob Ruijtenbeek …

Oncotarget 9(76) 34229-34239 2018年9月28日
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.

Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsushi Motegi, Katsuya Tsuchihara …

Oncotarget 9(34) 23844-23844 2018年5月4日
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.

Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsuhi Motegi, Katsuya Tsuchihara …

Oncotarget 9(27) 19368-19378 2018年4月10日
Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Hematological oncology 36(1) 76-83 2018年2月査読有り
Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Hematological oncology 35(4) 440-446 2017年12月査読有り
The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Leukemia & lymphoma 58(3) 736-739 2017年3月査読有り
Analysis of prognostic value of complete response by PET-CT and further stratification by clinical and biological markers in DLBCL patients.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Medical oncology (Northwood, London, England) 34(2) 29-29 2017年2月査読有り
A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Leukemia & lymphoma 57(10) 2460-3 2016年10月査読有り
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

Annals of hematology 95(10) 1661-9 2016年10月査読有り
Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.

Takeshi Sawada, Jungo Araki, Toshinari Yamashita, Manami Masubuchi, Tsuneko Chiyoda, Mayu Yunokawa, Kumiko Hoshi, Shoichi Tao, Shohei Yamamura, Shouki Yatsushiro …

EBioMedicine 11 173-182 2016年9月査読有り
Prognostic impact of CTC detected using a novel fluidic cell microarray chip CTC detection system in patients with breast cancer

Takeshi Sawada, Jungo Araki, Toshinari Yamashita, Manami Masubuchi, Tsuneko Chiyoda, Mayu Yunokawa, Kumiko Hoshi, Shoichi Tao, Shohei Yamamura, Shouki Yatsushiro …

CANCER RESEARCH 76(14_Supplement) 2016年7月査読有り
Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.

Takeshi Sawada, Masaru Watanabe, Yuu Fujimura, Shigehiro Yagishita, Tatsu Shimoyama, Yoshiharu Maeda, Shintaro Kanda, Mayu Yunokawa, Kenji Tamura, Tomohide Tamura …

Cancer science 107(3) 307-14 2016年3月査読有り

もっとみる

MISC

ポリADPリボース集積活性を有する抗がん剤候補MO2455の同定と構造活性相関

松野研司, 橋本知子, 小林寛幸, 大野修, ISLAM Rafiqul, 大川原正, 高村岳樹, 佐々木由香, 佐々木由香, 小野寺貴恵 …

メディシナルケミストリーシンポジウム講演要旨集 36th 2018年
Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

ANNALS OF ONCOLOGY 28 2017年10月
Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Ryoko Sekiya, Naoki Yanagisawa, Akifumi Imamura, Tsunekazu Hishima …

ANNALS OF ONCOLOGY 27 2016年7月
Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen

Yuta Ishiyama, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yusuke Kanemasa, Yasushi Omuro, Yoshiharu Maeda

ANNALS OF ONCOLOGY 27 2016年7月
乳癌研究:最近のトピックス【血中がん細胞診断血中循環腫瘍細胞測定・解析技術の臨床応用への期待】

小泉史明, 澤田武志

月刊細胞 48(7) 2016年
当科におけるGemcitabine/nab-paclitaxel療法を施行した進行・再発膵癌患者の検討

田村美宝, 小室泰司, 奥屋俊宏, 船坂知華子, 山口津加彩, 金政佑典, 澤田武志, 下山達, 前田義治

日本癌治療学会学術集会(Web) 54th 2016年
pegfilgrastim承認後のDLBCL患者におけるR-CHOP療法の相対治療強度の変化

金政佑典, 下山達, 佐々木友希, 山口津加彩, 船坂知華子, 田村美宝, 澤田武志, 小室泰司, 比島恒和, 前田義治

日本癌治療学会学術集会(Web) 54th 2016年
R-CHOP療法施行悪性リンパ腫患者におけるST合剤によるニューモシスチス肺炎予防に関する検討

石山雄太, 下山達, 佐々木友希, 田村美宝, 澤田武志, 金政佑典, 小室泰司, 前田義治

日本臨床腫瘍学会学術集会(CD-ROM) 14th 2016年
Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Sawada Takeshi, Eisaku Sasaki, Yasushi Omuro, Yoshiharu Maeda, Tsunekazu Hishima, Tsuneo Sasaki

ANNALS OF ONCOLOGY 26 85-86 2015年11月
Beta-2 microglobulin as a significant prognostic factor and a new risk model for diffuse large B-Cell lymphoma

Tsukasa Yamaguchi, Yusuke Kanemasa, Takeshi Sawada, Tatsu Shimoyama, Eisaku Sasaki, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda, Tsuneo Sasaki

ANNALS OF ONCOLOGY 26 97-97 2015年11月
Dielectrophoretic microwell array system for detection circulating tumor cells in patients with solid tumors and single cell analysis of detected circulating tumor cells

Takeshi Sawada, Atsushi Morimoto, Tatsu Shimoyama, Toshinari Yamashita, Toshifumi Mogami, Kazuki Iijima, Mayu Yunokawa, Shintaro Kanda, Yasuyuki Akiyama, Koji Katayama …

CANCER RESEARCH 75 2015年8月
Circulating tumor cells(CTC)―測定技術から分離解析技術への発展―

澤田武志, 小泉史明

がん分子標的治療 13(1) 85-91,4-5 2015年4月3日
次世代シーケンサーによる血中循環腫瘍細胞(CTC)の一細胞変異解析

鈴木智子, 鈴木智子, 澤田武志, 森本篤史, 下山達, 洪泰浩, 田村研治, 田村友秀, 二見達, 岡野栄之 …

日本人類遺伝学会大会プログラム・抄録集 60th 2015年
EGFR‐TKI耐性肺癌に対するgefitinib・PEM/S‐1併用療法および血漿中変異EGFRモニタリングの前向き試験

中原善朗, 中原善朗, 高木雄亮, 高木雄亮, 細見幸生, 影井亜貴子, 山本智宏, 澤田武志, 四方田真紀子, 大熊裕介 …

日本臨床腫瘍学会学術集会(CD-ROM) 13th ROMBUNNO.P3-1-66 2015年
成熟B細胞リンパ腫における髄液中DNA濃度の検討

澤田武志, 小泉史明, 斉藤誠, 金政佑典, 下山達, 佐々木栄作, 小室泰司, 前田義治

日本臨床腫瘍学会学術集会(CD-ROM) 13th ROMBUNNO.P1-9-4 2015年
A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of circulating tumor cells

Yasuhiro Koh, Masaru Watanabe, Takeshi Sawada, Hirotsugu Kenmotsu, Masakuni Serizawa, Masayuki Ishige, Kazuo Takeda, Nobuyuki Yamamoto, Toshiaki Takahashi, Fumiaki Koizumi

CANCER RESEARCH 74(19) 2014年10月
Effects of VEGF inhibition on skin ulcer induced by administration of cytotoxic anticancer drugs

Tatsu Shimoyama, Kiyoshi Ogura, Yuusuke Kanemasa, Shigeo Yamaguti, Eisaku Sasaki, Yasushi Omuro, Takeshi Sawada, Fumiaki Koizumi, Yoshiharu Maeda

CANCER RESEARCH 74(19) 2014年10月
A preclinical study of a novel FACS-based rare cell capture platform for the detection, capture and molecular characterization of circulating tumor cells.

Masaru Watanabe, Masakuni Serizawa, Takeshi Sawada, Yuu Fujimura, Fumiaki Koizumi, Yasuhiro Koh

MOLECULAR CANCER THERAPEUTICS 12(11) 2013年11月
新型セルソーターと次世代シークエンサーを用いた血中循環腫瘍細胞(CTC)の遺伝子変異解析の基礎検討

渡辺勝, 芹澤昌邦, 澤田武志, 伊藤由樹子, 藤村祐, 小泉史明, 洪泰浩

日本肺癌学会総会号 54th 430 2013年10月5日
Molecular characterization of captured circulating tumor cells with a novel cell sorting system

Maseru Watanabe, Takeshi Sawada, Masakuni Serizawa, Yukiko Ito, Yuu Fujimura, Fumiaki Koizumi, Yasuhiro Koh

CANCER RESEARCH 73(8) 2013年4月

もっとみる

講演・口頭発表等

Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

Kaname Nosaki, Hideo Saka, Yukio Hosomi, Paul Baas, Gilberto de, Castro Jr, Martin Reck, Yi-Long Wu, Julie R Brahmer, Enriqueta Felip, Takeshi Sawada, Kazuo Noguchi, Shi Rong Han, Bilal Piperdi, Debra A Kush, Gilberto Lopes

ESMO selected BEST Abstract plenary session 2019年4月
Immune system pathway activation for prediction of the response to neoadjuvant chemotherapy in triple negative breast cancer

Takeshi Sawada, Riet Hilhorst, Savithri Rangarajan, Masayuki Yoshida, Yuko Tanabe, Kenji Tamura, Takayuki Kinoshita, Rinie van Beuningen, Rob Ruijtenbeek, Hitoshi Tsuda, Fumiaki Koizumi

American Association for Cancer Research Annual Meeting 2017 2017年4月
Mutational analysis of primary tumors and single circulating tumor cells captured by a novel dielectrophoretic microwell array system in metastatic lung cancer, oral cancer and breast cancer patients

Takeshi Sawada, Atsushi Morimoto, Yasuyuki Akiyama, Tomoko Suzuki, Yukio Hosomi, Yusuke Okuma, Hirotoshi Horio, Masahiko Harada, Sadao Oyama, Chiharu Ogawa, Toshinari Yamashita, Yoshiharu Maeda, Tatsu Shimoyama, Tsunekazu Hishima, Fumiaki Koizumi

The 28th EORTC-NCI-AACR symposium 2016年12月
Developing Circulating Tumor Cell Detection Systems

The 1st Circulating Tumor Cell Forum 2016 2016年5月
Identification of a novel compound, MO2455, that induces poly(ADP-ribose) (PAR) accumulation and inhibits the growth of cancer cells in vitro and in vivo

Tatsu Shimoyama, Takeshi Sawada, Mari Akimoto, Yuka Sasaki, Hiroaki Fujimori, Yoshinobu Ishikawa, Tadashi Okawara, Tetsumi Irie, Takeji Takamura, Kenji Matsuno, Kengo Inoue, Mitsuko Masutani, Fumiaki Koizumi

American Association for Cancer Research Annual Meeting 2016 2016年4月
Prognostic impact of CTC detected using a novel fluidic cell microarray chip CTC detection system in patients with breast cancer

Takeshi Sawada, Jungo Araki, Toshinari Yamashita, Manami Masubuchi, Tsuneko Chiyoda, Mayu Yunokawa, Kumiko Hoshi, Shoichi Tao, Shohei Yamamura, Shouki Yatsushiro, Kaori Abe, Masatoshi Kataoka, Tatsu Shimoyama, Yoshiharu Maeda, Katsumasa Kuroi, Kenji Tamura, Tsuneo Sawazumi, Hironobu Minami, Yoshihiko Suda, Fumiaki Koizumi

American Association for Cancer Research Annual Meeting 2016 2016年4月
Circulating tumor cells as a potential sample for proof of concept studies in drug development

Takeshi Sawada, Masako Takatsu, Tomoko Suzuki, Mari Akimoto, Atsushi Morimoto, Yusuke Kanemasa, Tatsu Shimoyama, Yasushi Omuro, Toshinari Yamashita, Yoshiharu Maeda, Toru Futami, Fumiaki Koizumi

The 74th Annual Meeting of the Japanese Cancer Association 2015年10月
Evaluation of prognostic value of beta-2 microglobulin and a new risk model for DLBCL patients

Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Takeshi Sawada, Eisaku Sasaki, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda

The 77th Annual Meeting of the Japanese Society of Hematology 2015年10月
DNA fragments concentration in cerebrospinal fluid and CNS relapse risk in mature B-cell lymphoma

Takeshi Sawada, Fumiaki Koizumi, Makoto Saitoh, Yusuke Kanemasa, Tatsu Shimoyama, Eisaku Sasaki, Yasushi Omuro, Yoshiharu Maeda

The 77th Annual Meeting of the Japanese Society of Hematology 2015年10月
Dielectrophoretic microwell array system for detection circulating tumor cells in patients with solid tumors and single cell analysis of detected circulating tumor cells

Takeshi Sawada, Atsushi Morimoto, Tatsu Shimoyama, Toshinari Yamashita, Toshifumi Mogami, Kazuki Iijima, Mayu Yunokawa, Shintaro Kanda, Yasuyuki Akiyama, Koji Katayama, Masaru Watanabe, Yasuhiro Koh, Kenji Tamura, Tomohide Tamura, Toru Futami, Fumiaki Koizumi

American Association for Cancer Research Annual Meeting 2015 2015年4月
a novel dielectrophoretic microwell array system for detection and single cell analysis of circulating tumor cells from breast cancer patients

Takeshi Sawada, Atsushi Morimoto, Masaru Watanabe, Toshifumi Mogami, Kazuki Iijima, Yasuyuki Akiyama, Koji Katayama, Toru Futami, Mayu Yunokawa, Kenji Tamura, Yasuhiro Koh, Fumiaki Koizumi

The 26th EORTC-NCI-AACR SYMPOSIUM 2014年11月
Detection of EGFR mutation in cell free DNA in plasma from lung cancer patients before and after treatment of TKI

Takeshi Sawada, Tatsu Shimoyama, Yoshiharu Maeda, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Tomohide Tamura, Fumiaki Koizumi

The 73th Annual Meeting of the Japanese Cancer Association 2014年9月
Effects of VEGF inhibiton on skin ulcer induced by administration of cytotoxic anticancer drugs

Tatsu Shimoyama, Kiyoshi Ogura, Yuusuke Kanemasa, Shigeo Yamaguti, Eisaku Sasaki, Yasusi Omuro, Takeshi Sawada, Fumiaki Koizumi, Yoshiharu Maeda

American Association for Cancer Research Annual Meeting 2013 2014年4月
A preclinical study of a novel flow cytometry-based rare cell capture platform for the detection, capture and molecular characterization of circulating tumor cells

Masaru Watanabe, Masakuni Serizawa, Takeshi Sawada, Yuu Fujimura, Fumiaki Koizumi, Yasuhiro Koh

AACR-NCI-EORTC International Conference 2013 2013年11月
Clinical feasibility study of a novel sorting system for detecting EGFR mutations from captured circulating tumor cells in patients with lung cancer

Takeshi Sawada, Masaru Watanabe, Yasuhiro Koh, Yuu Fujimura, Hidehito Horinouchi, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Tomohide Tamura, Fumiaki Koizumi

15th World Conference on Lung Cancer 2013年10月
Clinical feasibility study of a novel sorting system for detecting PIK3CA mutations from captured circulating tumor cells in patients with breast cancer

Takeshi Sawada, Kenji Tamura, Yukiko Ito, Masaru Watanabe, Yuu Fujimura, Jun Hashimoto, Mayu Yunokawa, Yasuhiro Koh, Yasuhiro Fujiwara, Fumiaki Koizumi

The European Cancer Congress 2013 2013年9月
Molecular characterization of captured circulating tumor cells (CTCs) with a novel cell sorting system

Masaru Watanabe, Takeshi Sawada, Masakuni Serizawa, Yukiko Ito, Yuu Fujimura, Fumiaki Koizumi, Yasuhiro Koh

American Association for Cancer Research Annual Meeting 2013 2013年4月
Detection of circulating tumor cells for malignant epithelial tumor using a novel cytometry-based system

Yukiko Ito, Takeshi Sawada, Masaru Watanabe, Yuu Fujimura, Jun Hashimoto, Makoto Kodaira, Mayu Yunokawa, Harukaze Yamamoto, Kan Yonamori, Chikako Shimizu, Kenji Tamura, Yasuhiro Fujiwara, Yasuhiro Koh, Fumiaki Koizumi

American Association for Cancer Research Annual Meeting 2013 2013年4月

所属学協会

共同研究・競争的資金等の研究課題

ミトコンドリア置換技術を用いた、がん細胞におけるmtDNAの影響の解明

日本学術振興会科学研究費助成事業若手研究若手研究 2022年4月 - 2024年3月

澤田武志
固形癌に対するCPC-1 CAR-T療法の実用化に向けたex vivo 安全性/有効性評価法の確立

国立研究開発法人日本医療研究開発機構革新的がん医療実用化研究事業 2021年10月 - 2024年3月

澤田武志

基本情報

研究分野

経歴

学歴

受賞

論文

MISC

講演・口頭発表等

所属学協会

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧